US Stocks
/
BridgeBio Oncology Therapeutics, Inc. Share Price

BridgeBio Oncology Therapeutics, Inc. Share Price

NASDAQ: BBOT | Micro Cap
$3.41
-$0.03 (-1.02%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

BridgeBio Oncology Therapeutics, Inc. Stock Performance

Open
$3.37
Prev. Close
$3.44
Circuit Range
N/A
Day Range
$3.27 - $3.42
Year Range
$3.27 - $14.56
Volume
14,420
Average Traded
$3.36

BridgeBio Oncology Therapeutics, Inc. Share Price Today

As of 9 October 2026, BridgeBio Oncology Therapeutics, Inc.'s share price is $3.41. The stock opened at $3.37, compared to its previous close of $3.44. During today's trading session, BridgeBio Oncology Therapeutics, Inc.'s share price traded between $3.27 and $3.42, with an average price of $3.34. Over the past 52 weeks, the stock has recorded a high of $14.56 and a low of $3.27. In terms of performance, BridgeBio Oncology Therapeutics, Inc.'s share price has declined by 59.36% over the last six months and is down 71.32% on a year-on-year basis.

BridgeBio Oncology Therapeutics, Inc. Share Price Chart

$3.27$3.42
L
Show Current Price
H

BridgeBio Oncology Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$106.20M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.27
Revenue (TTM)
$0.00
Return On Equity (TTM)
-56.36%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-26.12%

BridgeBio Oncology Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$44.76-$38.80-$42.11-$56.45
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A13.32%-8.53%-34.05%

BridgeBio Oncology Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$134.04
Net Profit MarginN/A
Income ChangeN/A

About BridgeBio Oncology Therapeutics, Inc.

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.

BridgeBio Oncology Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$4.06
$3.42
-16.46%
Sep 2026
$8.63
$4.09
-55.35%
Aug 2026
$8.38
$9.17
+13.21%
Jul 2026
$7.75
$8.10
+6.30%
Jun 2026
$8.66
$7.62
-14.96%
May 2026
$8.40
$8.96
+6.79%
Apr 2026
$9.06
$8.39
-6.26%
Mar 2026
$10.00
$8.95
-10.54%
Feb 2026
$11.76
$10.01
-14.85%
Jan 2026
$12.05
$11.75
-5.55%
Dec 2025
$13.12
$12.44
+1.43%
Nov 2025
$12.02
$12.27
+3.15%

BBOT Share Price FAQs

What is BridgeBio Oncology Therapeutics, Inc. share price today?

chevron-up
BridgeBio Oncology Therapeutics, Inc. share price today is $3.41 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of BridgeBio Oncology Therapeutics, Inc. stock?

chevron-up
The 52 week high of BridgeBio Oncology Therapeutics, Inc. stock is $14.56, while the 52 week low is $3.27 as of 9 Oct '26.

What is BBOT's market capitalisation today?

chevron-up
BBOT market capitalisation is $106.20M as of October 9, 2026, at 4:45 pm IST.

What is BBOT's net income for the last quarter?

chevron-up
BBOT's net income for the last quarter is -56.45B USD.

What is the 5 year returns of BBOT?

chevron-up
The 5 year returns of BBOT is -67.48% as on 9 Oct '26.

What is the high & low stock price of BBOT today?

chevron-up
BBOT stock price hit a high of $3.42 and low of $3.27 as of 9 Oct '26.

Can I buy BBOT shares in India?

chevron-up
Yes. You can buy BBOT in India by opening an international trading account.